11/07/2024 6:42 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 6:52 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 7:31 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 6:02 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 6:04 AM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/17/2024 8:54 AM | Neurocrine Biosciences (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
09/17/2024 3:21 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
09/13/2024 3:23 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024 6:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2024 4:00 PM | Neurocrine Biosciences (Issuer) RASTETTER WILLIAM H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 4:06 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 4:12 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 4:21 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 4:16 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 4:18 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 4:40 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 9:51 AM | Neurocrine Biosciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024 6:03 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 6:04 AM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024 3:54 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 4:00 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 4:12 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 3:45 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 3:41 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:28 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 3:29 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 3:29 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 3:30 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 3:37 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024 8:36 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 8:09 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 3:38 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:51 PM | Neurocrine Biosciences (Issuer) RASTETTER WILLIAM H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:45 PM | Neurocrine Biosciences (Issuer) POON CHRISTINE A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 4:59 PM | Mercier Johanna (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:02 PM | Neurocrine Biosciences (Issuer) Norwalk Leslie V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:17 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:21 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:26 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:29 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 5:34 PM | Neurocrine Biosciences (Issuer) Sharp Shalini (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
05/21/2024 4:27 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:35 PM | Neurocrine Biosciences (Issuer) Sharp Shalini (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:15 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:57 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:06 PM | Neurocrine Biosciences (Issuer) Norwalk Leslie V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:51 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:46 PM | Mercier Johanna (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 3:31 PM | Neurocrine Biosciences (Subject) Norwalk Leslie V (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 3:31 PM | Neurocrine Biosciences (Subject) Sharp Shalini (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 3:32 PM | Neurocrine Biosciences (Subject) POPS RICHARD F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 3:40 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 3:23 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 3:26 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/01/2024 6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2024 6:03 AM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/17/2024 4:19 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 3:29 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:40 PM | Neurocrine Biosciences (Filer)
| Form ARS | |
04/10/2024 3:31 PM | Neurocrine Biosciences (Filer)
| Form DEFA14A | |
04/10/2024 3:07 PM | Neurocrine Biosciences (Filer)
| Form DEF 14A | |
04/03/2024 3:44 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 5:02 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:20 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:25 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:33 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:15 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:19 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 3:32 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024 3:33 PM | MORROW GEORGE J (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 5:47 PM | Neurocrine Biosciences (Issuer) Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 3:22 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 3:22 PM | Neurocrine Biosciences (Subject) POPS RICHARD F (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 5:55 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:02 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 5:50 PM | Neurocrine Biosciences (Issuer) Norwalk Leslie V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 4:11 PM | Neurocrine Biosciences (Issuer) POPS RICHARD F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:51 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:40 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:43 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:45 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:48 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:27 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:29 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:33 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:35 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:38 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 4:17 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 3:18 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:19 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
02/13/2024 3:19 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:20 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 3:20 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 4:29 PM | Neurocrine Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/08/2024 6:46 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:35 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:21 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:25 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 6:28 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |